Alex Sirois

Alex Sirois

Alex is a freelance contributor to InvestorPlace who provides investment insight that is conversational, actionable, and educational. While he writes about all stock classes, his personal stock investing style is focused on long-term, buy-and-hold, wealth-building stock picks.

Having worked in several industries from e-commerce to translation to education and utilizing his MBA from George Washington University, he brings a diverse set of skills through which he filters his writing. His number one goal in writing for InvestorPlace is to bring value to the reader.

You can follow Alex on LinkedIn.

Recent Articles

Sorrento Vaccine Hopes Are a Big ‘If’ With a Long Wait

SRNE stock won't appeal to many investors at this time. Click for news on its big hope among many plays.

Palantir Stock Is a Contrarian Play That’s Ready to Run Higher

PLTR stock speaks a strong message to some, and to others it represents something else entirely. That might help it run higher in the end.

The Road Ahead for Exxon Mobil Stock Is Still Filled With Barriers

XOM stock might look good on the vague notion that its problems are easily solved. But the issues for Exxon Mobil are actually much deeper.

Hyliion Stock Isn’t Worth Your Money At This Point

Hyliion stock might interest investors as part of the broader rush toward SPAC stocks. But not at this point. Here's more about its troubles.

7 Strong Nasdaq Stocks to Buy Before They Keep Marching Higher

Most Nasdaq stocks have seen ups and downs this year. But these seven have weathered the pandemic well and are bound to climb higher soon.